CD19 and neoplasm: The author further demonstrated that synNotch receptors are able to induce tumor-localized CAR expression in vivo, by using CAR-T cells with GFP synNotch receptor and inducible CD19-CAR gene against GFP+ CD19+ tumor cells (167).